Shares of Catalyst Pharmaceuticals fell 4.09% to $3.64 at 14:37 EST on Thursday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 0.68% to $12,744.50, after three consecutive sessions in a row of gains. This seems, up until now, a somewhat positive trend trading session today.
Catalyst Pharmaceuticals's last close was $3.79, 45.25% under its 52-week high of $5.28.
Catalyst Pharmaceuticals's Sales
Catalyst Pharmaceuticals's sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company's growth estimates for the ongoing quarter is 25% and a drop 10% for the next.
Catalyst Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals's Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals's stock is valued at $3.64 at 14:37 EST, way under its 52-week high of $5.28 and way higher than its 52-week low of $2.55.